The interest in peptides stems from their potential to combat neurodegeneration in diseases such as retinitis pigmentosa and glaucoma, with epialin being a molecule that can help repair or maintain the machinery lost in optic nerve damage conditions, which model diseases like glaucoma, retinitis pigmentosa, stroke, and traumatic head injury 10s
Practical Protocols for Using Copper Peptides Research findings are only useful if you can translate them into practical action
Conservative combination protocol (if attempting) Rationale for conservative approach: No safety data available Both peptides slow gastric emptying significantly Risk of severe GI complications Start low, go slow principle Tirzepatide component: Follow standard FDA-approved titration Weeks 1-4: 2.5mg weekly Weeks 5-8: 5mg weekly Weeks 9-12: 7.5mg weekly Weeks 13-16: 10mg weekly Week 17+: 12.5mg weekly (or stay at 10mg) Some reach 15mg weekly (maximum) Cagrilintide component (reduced from standard): Start AFTER tirzepatide stabilized at therapeutic dose (week 13+) Week 13-16: 0.6mg weekly (lower than standard) Week 17-20: 1.2mg weekly Week 21-24: 1.8mg weekly (may be maximum tolerable) Consider 2.4mg only if tolerating perfectly Conservative dosing comparison: Why sequential is safer: Tirzepatide establishes baseline first Can attribute new side effects to cagrilintide Easier to manage one variable at a time Option to stop cagrilintide if intolerable Less overwhelming than both simultaneously Expected benefits: 18-25% total weight loss (conservative estimate) Potentially superior to tirzepatide alone (15-22%) But incremental benefit may be modest (3-5% additional) Use SeekPeptides to plan sequential peptide additions safely
approved options with clear dosing will emerge Medical supervision is essential These potent compounds require qualified medical oversight Alternatives exist CagriSema and other evidence-based combinations offer proven approaches The rapid evolution of metabolic peptide research means today's experimental combinations may become tomorrow's standard therapiesor may prove ineffective or unsafe
Typically refrigerated at 28C
